Medicortex Finland Revenue and Competitors
Estimated Revenue & Valuation
- Medicortex Finland's estimated annual revenue is currently $2.6M per year.
- Medicortex Finland's estimated revenue per employee is $155,000
Employee Data
- Medicortex Finland has 17 Employees.
- Medicortex Finland grew their employee count by 6% last year.
Medicortex Finland's People
Name | Title | Email/Phone |
---|
Medicortex Finland Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Medicortex Finland?
Medicortex Finland Oy is a biotechnology company dedicated to developing diagnostics and treatments for acute neurodegenerative conditions, including brain injury and concussion. One of the company's missions is to identify a new biomarker in order to reliably assess the severity and extent of brain injury. Medicortex was founded by Dr. Adrian Harel in Turku, Finland, in 2014 and it operates as a privately owned company. Dr. Harel has a track record in the business management and leadership of early-stage biotechnology companies. ---- Kuvaus suomeksi: Medicortex Finland Oy (http://www.medicortex.fi) on bioteknologian alan yritys, joka on keskittynyt parantamaan aivovammojen (TBI) diagnostiikka ja hoitoa. Yrityksen nykyinen painopiste on kehittää biomerkkiaineisiin perustuvaa diagnostiikkaa, jolla pystytään arvioimaan aivovamman laajuutta ja vaikeusastetta.
keywords:N/AN/A
Total Funding
17
Number of Employees
$2.6M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.1M | 21 | N/A | N/A |
#2 | $2.6M | 23 | -4% | N/A |
#3 | N/A | 25 | 525% | N/A |
#4 | $2.5M | 26 | 8% | N/A |
#5 | $5.4M | 27 | -4% | N/A |